Adults 65 years of age and older are at increased risk for influenza-related complications, hospitalizations, and death. Older age is associated with a progressive decline in the immune response to infectious diseases, including influenza, and a diminished immune response to many vaccines. Influenza outbreaks continue to occur even in long-term care facilities in which most residents have been immunized, and these outbreaks can carry considerable human and economic costs. This non-CME webcast will review pertinent clinical information about influenza in older adults, including epidemiology and disease burden, the key role of immunization, and the importance of using a vaccine that has been shown to improve protection against influenza in this vulnerable population.
Stefan Gravenstein, MD, MPH, MA, CMD, AGSF, FACP
Professor of Medicine and Health Services, Policy and Practice
Schools of Medicine and Public Health
Providence, Rhode Island
Adjunct Professor of Medicine and Family Medicine
University Hospitals Cleveland Medical Center and
Case Western Reserve University
In accordance with Sanofi Pasteur’s policies and the PhRMA Code on Interactions with Healthcare Professionals, attendance at this educational program is limited to health care professionals.
Value transfers to licensed health care professionals by pharmaceutical companies need to be reported according to certain state laws, as well as Federal Sunshine Act provisions.
Facilitated by PRI Healthcare Solutions.
This is a non-CME educational event. CME credit will not be available for this session.